ScholarIQanswers from OpenAlex & ORCID
C. Zhou
ResearcherPublications, citations & collaboration network
C. Zhou is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does C. Zhou have?
ScholarIQindexed works
C. Zhou has 118 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does C. Zhou have?
ScholarIQcitation count
C. Zhou has 1,431 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of C. Zhou?
ScholarIQh-index
C. Zhou has an h-index of 12 in OpenAlex.
What is the i10-index of C. Zhou?
ScholarIQi10-index
C. Zhou has an i10-index of 13 in OpenAlex.
What is the ORCID of C. Zhou?
ScholarIQorcid
The ORCID for C. Zhou is on the source record.
What is the OpenAlex record for C. Zhou?
ScholarIQopenalex
The OpenAlex for C. Zhou is on the source record.
What are the most-cited papers on C. Zhou?
ScholarIQmost cited works
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)
C. Zhou, Yi‐Long Wu, G. Chen, J. Feng, Xuetong Liu, C. Wang, S. Zhang, J. Wang, Songwen Zhou, Shengxiang Ren, Shun Lü, L. Zhang, Chengping Hu, Chengping Hu, Yi Luo, Lin Chen, M. Ye, Juanjuan Huang, X. Zhi, Y. Zhang, Qingyu Xiu, W. F. Mader, L. Zhang, Changxuan You
Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study
Suresh S. Ramalingam, Yi Cheng, C. Zhou, Y. Ohe, Fumio Imamura, Byoung Chul Cho, Meng‐Chih Lin, Margarita Majem, Riyaz Shah, Yuri Rukazenkov, A. Todd, Aleksandra Markovets, J. Carl Barrett, Juliann Chmielecki, Jhanelle E. Gray
Metformin Reprograms Tryptophan Metabolism to Stimulate CD8+ T-cell Function in Colorectal Cancer
Xiaowen Huang, Tiantian Sun, Jilin Wang, Xialu Hong, Huimin Chen, Tingting Yan, C. Zhou, Danfeng Sun, Chen Yang, TaChung Yu, Wenyu Su, Wan Du, Hua Xiong
ROS1 fusions in Chinese patients with non-small-cell lung cancer
W. Cai, X. Li, Chunxia Su, Lihong Fan, Li-Mou Zheng, K. Fei, C. Zhou, C. Manegold, Gerald Schmid‐Bindert
2O IMpower010: Biomarkers of disease-free survival (DFS) in a phase III study of atezolizumab (atezo) vs best supportive care (BSC) after adjuvant chemotherapy in stage IB-IIIA NSCLC
C. Zhou, Meghna Das Thakur, Manoj Srivastava, Wen Zou, Hongjie Xu, M. Ballinger, Enriqueta Felip, Heather A. Wakelee, Nasser K. Altorki, Martin Reck, Rüediger Liersch, Anna Kryzhanivska, M. Harada, Hiroshi Tanaka, John Hamm, Steve McCune, Virginia McNally, Elizabeth Bennett, Barbara J. Gitlitz, Silvia Novello